189 related articles for article (PubMed ID: 30248101)
1. Impact of MMP-2 and MMP-9 enzyme activity on wound healing, tumor growth and RACPP cleavage.
Hingorani DV; Lippert CN; Crisp JL; Savariar EN; Hasselmann JPC; Kuo C; Nguyen QT; Tsien RY; Whitney MA; Ellies LG
PLoS One; 2018; 13(9):e0198464. PubMed ID: 30248101
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.
Garg P; Vijay-Kumar M; Wang L; Gewirtz AT; Merlin D; Sitaraman SV
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G175-84. PubMed ID: 19171847
[TBL] [Abstract][Full Text] [Related]
3. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
4. Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function.
Chen EP; Markosyan N; Connolly E; Lawson JA; Li X; Grant GR; Grosser T; FitzGerald GA; Smyth EM
Carcinogenesis; 2014 Aug; 35(8):1788-97. PubMed ID: 24590894
[TBL] [Abstract][Full Text] [Related]
5. Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides.
Hingorani DV; Lemieux AJ; Acevedo JR; Glasgow HL; Kedarisetty S; Whitney MA; Molinolo AA; Tsien RY; Nguyen QT
Oral Oncol; 2017 Aug; 71():156-162. PubMed ID: 28688684
[TBL] [Abstract][Full Text] [Related]
6. Macrophage overexpression of matrix metalloproteinase-9 in aged mice improves diastolic physiology and cardiac wound healing after myocardial infarction.
Meschiari CA; Jung M; Iyer RP; Yabluchanskiy A; Toba H; Garrett MR; Lindsey ML
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H224-H235. PubMed ID: 29030341
[TBL] [Abstract][Full Text] [Related]
7. Matrix-metalloproteinases in head and neck carcinoma-cancer genome atlas analysis and fluorescence imaging in mice.
Hauff SJ; Raju SC; Orosco RK; Gross AM; Diaz-Perez JA; Savariar E; Nashi N; Hasselman J; Whitney M; Myers JN; Lippman SM; Tsien RY; Ideker T; Nguyen QT
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):612-8. PubMed ID: 25091190
[TBL] [Abstract][Full Text] [Related]
8. Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing.
Julovi SM; McKelvey K; Minhas N; Chan YA; Xue M; Jackson CJ
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203540
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion.
Suofu Y; Clark JF; Broderick JP; Kurosawa Y; Wagner KR; Lu A
Neuroscience; 2012 Jun; 212():180-9. PubMed ID: 22521821
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
[TBL] [Abstract][Full Text] [Related]
11. Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.
Felsen CN; Savariar EN; Whitney M; Tsien RY
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L764-74. PubMed ID: 24508733
[TBL] [Abstract][Full Text] [Related]
12. Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.
Deryugina EI; Zajac E; Juncker-Jensen A; Kupriyanova TA; Welter L; Quigley JP
Neoplasia; 2014 Oct; 16(10):771-88. PubMed ID: 25379015
[TBL] [Abstract][Full Text] [Related]
13. Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.
Metildi CA; Felsen CN; Savariar EN; Nguyen QT; Kaushal S; Hoffman RM; Tsien RY; Bouvet M
Ann Surg Oncol; 2015; 22(6):2082-7. PubMed ID: 25319581
[TBL] [Abstract][Full Text] [Related]
14. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and their inhibitors in canine mammary tumors.
Aresu L; Giantin M; Morello E; Vascellari M; Castagnaro M; Lopparelli R; Zancanella V; Granato A; Garbisa S; Aricò A; Bradaschia A; Mutinelli F; Dacasto M
BMC Vet Res; 2011 Jul; 7():33. PubMed ID: 21726449
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis.
Marjon NA; Hu C; Hathaway HJ; Prossnitz ER
Mol Cancer Res; 2014 Nov; 12(11):1644-1654. PubMed ID: 25030371
[TBL] [Abstract][Full Text] [Related]
17. Molecular events involved in the increased expression of matrix metalloproteinase-9 by T lymphocytes of mammary tumor-bearing mice.
Owen JL; Torroella-Kouri M; Iragavarapu-Charyulu V
Int J Mol Med; 2008 Jan; 21(1):125-34. PubMed ID: 18097625
[TBL] [Abstract][Full Text] [Related]
18. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression.
Qin L; Liao L; Redmond A; Young L; Yuan Y; Chen H; O'Malley BW; Xu J
Mol Cell Biol; 2008 Oct; 28(19):5937-50. PubMed ID: 18644862
[TBL] [Abstract][Full Text] [Related]
19. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo.
Zhang W; Matrisian LM; Holmbeck K; Vick CC; Rosenthal EL
BMC Cancer; 2006 Mar; 6():52. PubMed ID: 16515711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
